Found 167 clinical trials
Stem Cell Transplant in Patients With Severe Sickle Cell Disease
-myeloablative conditioning regimen (Alemtuzumab).
- 30 views
- 02 Apr, 2021
- 1 location
Ruxolitinib and Decitabine for High Risk Hematological Malignancies
The purpose of this study is to determine the efficacy and safety of Ruxolitinib and Decitabine intensified Conditioning Regimen in Patients with High Risk hematological malignancies undergoing
- 0 views
- 25 Jan, 2021
- 1 location
Clofarabine Pre-allogeneic Stem Cell Transplant for Non-remission AML
The Investigators would like to study the incidence of complete remission (CR) at day +30 after Clofarabine followed by haploidentical transplant. The conditioning regimen used is Fludarabine
- 0 views
- 27 Jan, 2021
- 1 location
Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD)
transplant with either a myeloablative or non-myeloablative conditioning regimen, and recipients of all donor sources will be enrolled to this trial.
- 0 views
- 24 May, 2021
- 1 location
Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission
antagonist, as a chemo sensitization strategy, plus chemotherapy as the conditioning regimen for autologous or allogeneic hematopoietic stem cell transplantation (HSCT).
- 17 views
- 24 Jan, 2021
- 1 location
Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia
cell transplantation (allo-HSCT) adding gemcitabine to the standard institutional conditioning regimen based on two alkylating drugs, reduced busulfan and cyclophosphamide (reduced BUCY 2).
- 1 views
- 24 Jan, 2021
- 1 location
Early Diagnosis and Stem Cell Transplantation for Severe Immunodeficiency Diseases
The hypothesis of this study is that children with severe primary immunodeficiencies will benefit from early stem cell transplantation utilizing a reduced intensity conditioning regimen
- 8 views
- 07 Nov, 2020
- 1 location
Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies
This is a Phase II trial to determine the ability of a reduced intensity conditioning regimen to allow successful engraftment with alpha/beta T and CD19+ depleted peripheral stem cell grafts
- 3 views
- 24 Jan, 2021
- 1 location
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
The purpose of this study is to evaluate the safety of reducing and ultimately eliminating anti-thymocyte globulin (ATG) from the haplo-cord transplant conditioning regimen and replacing it with
- 0 views
- 26 Jan, 2021
- 1 location
Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor
The aim of this study to evaluate the safety and efficacy of a nonmyeloablative conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSCT) in pediatric patients with
- 9 views
- 03 Jun, 2021
- 1 location